Comparisons of Clinical Outcomes in Women with Advanced Ovarian Cancer Treated with Frontline Intraperitoneal versus Dose-Dense Platinum/Paclitaxel Chemotherapy without Bevacizumab

Background: We aimed to compare the clinical outcomes between intraperitoneal chemotherapy and dose-dense chemotherapy for the frontline treatment of advanced ovarian, fallopian tube and primary peritoneal cancer in women not receiving bevacizumab. Methods: All consecutive women with stage II~IV can...

Descripción completa

Detalles Bibliográficos
Autores principales: Ting, Wan-Hua, Hsiao, Chi-Huang, Chen, Hui-Hua, Wei, Ming-Chow, Lin, Ho-Hsiung, Hsiao, Sheng-Mou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277334/
https://www.ncbi.nlm.nih.gov/pubmed/32443934
http://dx.doi.org/10.3390/ijerph17103603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277334/
https://www.ncbi.nlm.nih.gov/pubmed/32443934
http://dx.doi.org/10.3390/ijerph17103603

Ejemplares similares